Bio Key International Stock Today

BKYI Stock  USD 0.90  0.02  2.17%   

Performance

2 of 100

 
Weak
 
Strong
Weak

Odds Of Distress

Over 84

 
High
 
Low
Very High
BIO Key is trading at 0.9 as of the 30th of November 2024. This is a 2.17 percent decrease since the beginning of the trading day. The stock's open price was 0.92. BIO Key has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for BIO Key International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain
Software & Services
IPO Date
14th of February 1997
Category
Industrials
Classification
Information Technology
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company has 3.11 M outstanding shares of which 152.66 K shares are currently shorted by private and institutional investors with about 0.16 trading days to cover. More on BIO Key International

Moving against BIO Stock

  0.64ALLE Allegion PLCPairCorr
  0.59JG Aurora MobilePairCorr
  0.52BL BlacklinePairCorr
  0.48U Unity Software Aggressive PushPairCorr
  0.48DQ Daqo New EnergyPairCorr
  0.48DT Dynatrace Holdings LLCPairCorr

BIO Stock Highlights

MD ViceChairmanKwok Wong
Business ConcentrationSystems Software, Security & Protection Services, Information Technology, NASDAQ Composite, Information Technology, Software, Security & Protection Services, Industrials (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover1.81.7168
Sufficiently Up
Pretty Stable
Total Current Liabilities3.1 M3.2 M
Sufficiently Down
Slightly volatile
Total Assets4.3 M4.5 M
Notably Down
Slightly volatile
Total Current AssetsM2.6 M
Way Up
Slightly volatile
Debt Levels
BIO Key can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand BIO Key's financial leverage. It provides some insight into what part of BIO Key's total assets is financed by creditors.
Liquidity
BIO Key International currently holds 365.35 K in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. BIO Key International has a current ratio of 3.43, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about BIO Key's use of debt, we should always consider it together with its cash and equity.

Change In Working Capital

(256,271)
BIO Key International (BKYI) is traded on NASDAQ Exchange in USA. It is located in 101 Crawfords Corner Road, Holmdel, NJ, United States, 07753 and employs 43 people. BIO Key is listed under Systems Software category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.25 M. BIO Key International conducts business under Software sector and is part of Information Technology industry. The entity has 3.11 M outstanding shares of which 152.66 K shares are currently shorted by private and institutional investors with about 0.16 trading days to cover. BIO Key International currently holds about 4.89 M in cash with (3.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Check BIO Key Probability Of Bankruptcy
Ownership Allocation
BIO Key International shows 5.57 percent of its outstanding shares held by insiders and 5.02 percent owned by other corporate entities.
Check BIO Ownership Details

BIO Stock Institutional Holders

InstituionRecorded OnShares
Abich Financial Wealth Management Llc2024-09-30
0.0
Group One Trading, Lp2024-06-30
0.0
Geode Capital Management, Llc2024-09-30
0.0
Armistice Capital, Llc2024-09-30
250 K
Tower Research Capital Llc2024-06-30
5.9 K
Ubs Group Ag2024-06-30
2.4 K
Advisor Group Holdings, Inc.2024-06-30
262
Jpmorgan Chase & Co2024-06-30
71.0
Headlands Technologies Llc2024-09-30
16.0
Bank Of America Corp2024-06-30
14.0
Harbour Investments, Inc.2024-09-30
6.0
View BIO Key Diagnostics

BIO Key Historical Income Statement

As of now, BIO Key's Reconciled Depreciation is decreasing as compared to previous years. View More Fundamentals

BIO Stock Against Markets

BIO Key Corporate Management

Cecilia WelchChief OfficerProfile
Akintunde JejeManaging AfricaProfile
Alex RochaManaging EMEAProfile
Mira LaCousChief OfficerProfile
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.66)
Revenue Per Share
6.323
Quarterly Revenue Growth
(0.41)
Return On Assets
(0.56)
Return On Equity
(4.58)
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.